Masimo (MASI) Stock Price
Masimo Price
Over the last 19 years Masimo grew revenue by 10.6% annually, reaching 1.53 B USD. Earnings per share have grown at 1.5% per year over the last 17 years. For Masimo, the net margin of -9.9% is down versus 18.5% a few years ago. At today's price the dividend yield works out to roughly 0.56%. The payout ratio is around 93% of earnings.
Masimo stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Masimo over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Masimo stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Masimo's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Masimo Price |
|---|
Masimo Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Masimo Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|
| 2.04 | 1.28 | 1.4 | 1.53 | 1.66 | 1.78 | 1.92 | 2.01 |
| 64.25 | -37.35 | 9.41 | 9.39 | 8.65 | 7.6 | 7.4 | 5.11 |
| 51.99 | 60 | 56.92 | 61.93 | 57 | 52.97 | 49.32 | 46.92 |
| 1.06 | 0.77 | 0.79 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| 143 | 81 | -304 | -151 | 322 | 361 | 406 | 406 |
| -37.55 | -43.36 | -475.31 | -50.33 | -313.25 | 12.11 | 12.47 | – |
| - | - | - | - | 8.3 | 9.32 | 10.46 | - |
| – | – | – | – | – | 12.29 | 12.23 | – |
| 55.2 | 54.1 | 53.3 | 53.6 | 53.6 | 53.6 | 53.6 | 53.6 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Masimo generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Masimo retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Masimo's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Masimo has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Masimo's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Masimo stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Masimo Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Masimo business model & stock analysis
Masimo SWOT Analysis
Strengths
Masimo Corp has several key strengths that contribute to its success in the market. Firstly, the company is known for its innovative and advanced medical monitoring technologies, which provide real-time and reliable patient data. This technological expertise not only sets Masimo apart from its competitors but also allows it to continuously introduce new and improved products to meet customer needs.
Secondly, Masimo has established a strong brand reputation as a trusted and reliable provider of medical devices. Healthcare professionals and hospitals have come to rely on Masimo's products for accurate and actionable data, enhancing patient care and improving outcomes. This brand recognition creates a competitive advantage for the company and increases customer loyalty.
Furthermore, Masimo has a global presence with distribution channels spanning across various regions. This extensive network enables the company to reach a diverse customer base and capitalize on opportunities in different markets.
Weaknesses
Despite its strengths, Masimo Corp also faces certain weaknesses that pose challenges to its growth. One weakness is the company's dependence on a limited number of key customers, which puts it at risk if any of these customers were to reduce their orders or switch to competitors. Diversifying the customer base would mitigate this risk.
Another weakness is the high research and development costs associated with developing and enhancing its innovative products. While this investment is necessary for staying ahead in the industry, it can strain the company's financial resources and profitability in the short term.
Opportunities
Masimo Corp operates in a healthcare industry that is constantly evolving and growing, presenting several opportunities for the company. One opportunity is the increasing adoption of remote patient monitoring and telehealth services, which are becoming more prevalent in healthcare systems worldwide. Masimo can leverage its technological expertise to develop solutions for these emerging trends, expanding its customer base and revenue streams.
Furthermore, the rising global healthcare expenditure provides a favorable market environment for Masimo. As governments and healthcare providers invest in improving patient care and outcomes, the demand for advanced medical monitoring technologies is expected to increase. By focusing on market penetration strategies and partnerships with healthcare organizations, Masimo can capitalize on this growing demand.
Threats
In addition to opportunities, Masimo Corp faces certain threats in its industry that must be addressed. One significant threat is the intense competition from other medical device companies. The market for medical monitoring technologies is highly competitive, and new entrants and existing competitors pose a risk to Masimo's market share.
Another threat is the regulatory environment for medical devices. Compliance with stringent regulations and obtaining necessary approvals can be time-consuming and costly. Changes in regulations or non-compliance could hinder Masimo's ability to bring products to market in a timely manner.
Lastly, economic downturns and fluctuations in healthcare spending can impact the demand for medical devices. A decrease in healthcare budgets or a slowdown in hospital investments could result in reduced demand for Masimo's products.
Masimo Segments
Masimo Eulerpool Fair Value
Masimo historical P/E ratio, EBIT multiple, and P/S ratio
Masimo annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Masimo shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Masimo Dividend History
2 years of dividend payments
Masimo dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Masimo Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/4/2026 | 1.46USD | 406.06 MUSD | 2026 Q1 |
| 2/26/2026 | 1.51USD | 416.48 MUSD | 2025 Q4 |
| 5/7/2024 | 0.7USD | 526.4 MUSD | 2024 Q1 |
| 2/26/2024 | 0.81USD | 547.65 MUSD | 2023 Q4 |
| 8/7/2023 | 1.05USD | 579.77 MUSD | 2023 Q2 |
| 5/1/2023 | 0.95USD | 562.96 MUSD | 2023 Q1 |
| 2/13/2023 | 1.2USD | 611.53 MUSD | 2022 Q4 |
| 11/8/2022 | 0.94USD | 541.44 MUSD | 2022 Q3 |
| 8/9/2022 | 1.23USD | 548.67 MUSD | 2022 Q2 |
| 5/3/2022 | 0.89USD | 308.39 MUSD | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Masimo stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Masimo shareholder structure
| % | Name |
|---|---|
12.22151% | |
8.55715% | |
8.0927% | |
7.95671% | |
4.96057% | |
4.89146% |
Masimo Executives and Management Board
Mr. Micah Young
(46)Chief Financial Officer, Executive Vice President
Mr. Blair Tripodi
(51)Chief Operating Officer - Consumer Division
Ms. Michelle Brennan
(59)Chairman of the Board · since 2023
Mr. Quentin Koffey
(46)Lead Independent Vice Chairman of the Board
Dr. Darlene Solomon
(66)Independent Director
Frequently asked questions about Masimo
The business model of Masimo Corp focuses on providing innovative noninvasive monitoring technologies. Masimo develops and manufactures a wide range of medical devices and sensors to improve patient outcomes and reduce healthcare costs. The company's flagship product, Masimo SET®, revolutionized pulse oximetry by offering accurate measurements even in challenging conditions. With a dedication to patient safety and care, Masimo Corp combines advanced signal processing and sensor technology to deliver reliable monitoring solutions to healthcare professionals. Through their product portfolio, Masimo Corp aims to enhance patient care and promote efficiency in the healthcare industry.
Masimo stock
Masimo Peer Group
Masimo Ticker
Masimo FIGI
All fundamentals and in-depth analysis of Masimo
Our stock analysis for Masimo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Masimo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.